ROKIT Healthcare, a Korean 3D bioprinter manufacturer previously known as ROKIT, has introduced a novel 3D bioprinting method to treat scarred lesions. Using the company’s 3D bioprinter, the ROKIT INVIVO, to 3D print a patient’s autologous tissues and cells into a dermal patch graft. When placed on a wound, the 3D printed dermal patch graft […]
157 Replies to “ROKIT Healthcare develops novel 3D bioprinting method to treat lesions”
Comments are closed.